SCHEMBL25069783

SCHEMBL25069783

CCn1cc(C(=O)OC2CCC(N)CC2)c(=O)c2cc(F)c(Cl)cc21

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.50
▸ HSD17B10 Q99714 5/20 0.49
▸ KDM4E B2RXH2 5/20 0.49
▸ HPGD P15428 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ KMT2A Q03164 4/20 0.48
▸ GAA P10253 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ RAD52 P43351 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ BRD4 O60885 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ CYP2J2 P51589 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8041564 0.83 POLB (0.69) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL29823822 0.83 POLB (0.69) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL10472032 0.82 POLB (0.55) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL541725 0.81 POLB (0.54) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL6200992 0.79 KMT2A (0.51) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL27604268 0.79 POLB (0.53) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL10857506 0.78 HPGD (0.44) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL28433719 0.78 POLB (0.58) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL8500940 0.78 KMT2A (0.52) POLBHSD17B10KDM4EHPGDALDH1A1
SCHEMBL29548224 0.78 DRD3 (0.63) POLBHSD17B10KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME Frequency Therapeutics, Inc. (US) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME DCX, NES, MCL1 POLB 2058/4885HSD17B10 783/4885KDM4E 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback